Menachem Fromer
About Menachem Fromer
Menachem Fromer serves as the Vice President of Data Science at ROME Therapeutics and holds the position of Associate Professor at the Icahn School of Medicine at Mount Sinai. He has a background in computational biology, having worked at The Broad Institute and Verily Life Sciences, and has an extensive educational history in computer science and biology.
Current Role at ROME Therapeutics
Menachem Fromer serves as the Vice President of Data Science at ROME Therapeutics. He has held this position since 2021, contributing to the company's focus on developing innovative therapies through advanced data science methodologies. His role involves leading data-driven strategies to enhance therapeutic development.
Professional Experience at The Broad Institute
From 2010 to 2020, Menachem Fromer worked at The Broad Institute of MIT and Harvard as a Computational Biologist. During his tenure, he engaged in various research projects that integrated computational methods with biological data to advance scientific understanding in genomics and related fields.
Academic Position at Icahn School of Medicine
Menachem Fromer has been an Associate Professor at the Icahn School of Medicine at Mount Sinai since 2012. In this role, he is involved in both teaching and research, focusing on the intersection of data science, computer science, and biology.
Education Background
Menachem Fromer studied at The Hebrew University of Jerusalem from 1999 to 2010, where he completed his education. He also attended HAFTR and Machon Lev, which contributed to his foundational knowledge in the fields of computer science and biology.
Previous Role at Verily Life Sciences
Before joining ROME Therapeutics, Menachem Fromer worked as a Data Science Group Leader at Verily Life Sciences from 2016 to 2021. In this role, he led a team focused on applying data science techniques to health-related challenges, furthering the mission of improving health outcomes through data-driven insights.